Professor Mark Hutchinson is an ARC Australian Research Fellow and is the Director of the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP), he is also a Professor within the School of Medicine at the University of Adelaide. Professor Hutchinson returned to the University of Adelaide in 2009 as an NHMRC CJ Martin Research Fellow, and established the Neuroimmunopharmacology research laboratory. From 2005 to 2009 Mark worked in the world-leading laboratory of Professor Linda Watkins in the Center for Neuroscience at the University of Colorado at Boulder. Here he pioneered with Professor Watkins the research which has led to the discovery of novel drug activity at innate immune receptors.
Professor Hutchinson’s research has implicated the brain immune-like cells in the action of drugs of dependence and the negative side effects of pain treatments. His work has enabled the translation of compounds at the lab bench to clinical agents used at the bedside.
Professor Hutchinson has published over 100 papers in journals and refereed conference proceedings. He has now added Director of the CNBP to his roles. The CNBP is an ARC Centre of Excellence headquartered at The University of Adelaide, with nodes at Macquarie University, Sydney and the RMIT, Melbourne. They are partnered with universities and companies in Europe, the US and China, as well as other Australian institutions. The CNBP has a mission to “Discover new approaches to measure nano-scale dynamic phenomena in living systems”.
Professor Hutchinson will be presenting The “toll” of knowing you are sick: Implications for acute pain management and consequences for chronic agony.
We are delighted to have Professor Mark Hutchinson involved in APS 2017, we hope you will be able to attend and enjoy everything this conference has to offer.
Register for the 2017 Australian Pain Society 37th Annual Scientific Meeting.
Follow #auspain2017 on Twitter.
Australian Pain Society 